title: Iodide suppression of major histocompatibility class I gene expression in thyroid cells involves enhancer A and the transcription factor NF-kappa B.
abstract: High concentrations of iodide can induce transient, clinical improvement in patients with autoimmune Graves' disease. Previous work has related this iodide action to the autoregulatory effect of iodide on the growth and function of the thyroid; more recently, we additionally related this to the ability of iodide to suppress major histocompatibility (MHC) class I RNA levels and antigen expression on thyrocytes. In this report, we describe a transcriptional mechanism involved in iodide suppression of class I gene expression, which is potentially relevant to the autoregulatory action of iodide. Transfection experiments in FRTL-5 cells show that iodide decreases class I promoter activity and that this effect can be ascribed to the ability of iodide to modulate the formation of two specific protein/DNA complexes with enhancer A, -180 to -170 bp, of the class 1 5'-flanking region. Thus, iodide decreases the formation of Mod-1, an enhancer A complex involving the p50 subunit of NF-kappa B and a c-fos family member, fra-2, which was previously shown to be important in the suppression of class I levels by hydrocortisone. Unlike hydrocortisone, iodide also increases the formation of a complex with enhancer A, which we show, in antibody shift experiments, is a heterodimer of the p50 and p65 subunits of NF-kappa B. The changes in these complexes are not duplicated by chloride and are related to the action of iodide on class I RNA levels by the following observations. First, FRTL-5 thyroid cells with an aged phenotype coincidentally lose the ability of iodide to decrease MHC class I RNA levels and to induce changes in either complex. Second, the effect of iodide on class I RNA levels and on enhancer A complex formation with Mod-1 and the p50/p65 heterodimer is inhibited by agents that block the inositol phosphate, Ca++, phospholipase A2, arachidonate signal transduction pathway: acetylsalicylate, indomethacin, and 5,8,11,14-eicosatetraynoic acid. Interestingly, iodide can also decrease formation of the Mod-1 complex and increase formation of the complex with the p50/p65 subunits of NF-kappa B when the NF-kappa B enhancer sequence from the Ig kappa light chain, rather than enhancer A, is used as probe; and both actions mimic the action of a phorbol ester. This suggests that iodide may regulate complex formation with NF-kappa B regulatory elements on multiple genes associated with growth and function, providing a potential mechanism relating the autoregulatory action of iodide on thyroid cells and its action on class I gene expression.
authors.affiliation: Cell Regulation Section, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland 20892, USA.
authors.forename: S I
authors.initials: SI
authors.lastname: Taniguchi
authors.forename: M
authors.initials: M
authors.lastname: Shong
authors.forename: C
authors.initials: C
authors.lastname: Giuliani
authors.forename: G
authors.initials: G
authors.lastname: Napolitano
authors.forename: M
authors.initials: M
authors.lastname: Saji
authors.forename: V
authors.initials: V
authors.lastname: Montani
authors.forename: K
authors.initials: K
authors.lastname: Suzuki
authors.forename: D S
authors.initials: DS
authors.lastname: Singer
authors.forename: L D
authors.initials: LD
authors.lastname: Kohn
mesh_terms: D000818:Animals; D002118:Calcium / Q000502:physiology; D002417:Cattle; D002460:Cell Line; D016922:Cellular Senescence / Q000187:drug effects / Q000235:genetics; D019281:Dimerization; D004742:Enhancer Elements, Genetic / Q000187:drug effects*; D005786:Gene Expression Regulation / Q000187:drug effects*; D005805:Genes, MHC Class I / Q000187:drug effects*; D007454:Iodides / Q000494:pharmacology*; D046911:Macromolecular Substances; D016328:NF-kappa B / Q000187:drug effects / Q000378:metabolism / Q000502:physiology*; D052002:NF-kappa B p50 Subunit; D010641:Phenotype; D010716:Phosphatidylinositols / Q000502:physiology; D011401:Promoter Regions, Genetic / Q000187:drug effects; D011451:Prostaglandin-Endoperoxide Synthases / Q000502:physiology; D012313:RNA / Q000187:drug effects / Q000378:metabolism; D051381:Rats; D015398:Signal Transduction; D013552:Swine; D013961:Thyroid Gland / Q000166:cytology / Q000378:metabolism*; D051996:Transcription Factor RelA
chemical_list: D007454:Iodides; D046911:Macromolecular Substances; D016328:NF-kappa B; D052002:NF-kappa B p50 Subunit; D010716:Phosphatidylinositols; D051996:Transcription Factor RelA; D012313:RNA; D011451:Prostaglandin-Endoperoxide Synthases; D002118:Calcium